health alert: Roche and Biogen Idec have suspended trials of Ocrelizumab treatment in patients with rheumatoid arthritis due to safety concerns Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, March 13, 2010

health alert: Roche and Biogen Idec have suspended trials of Ocrelizumab treatment in patients with rheumatoid arthritis due to safety concerns



Blogger
add your opinions

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments ( Atom )